Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
Several clinical trials have demonstrated the efficacy of lytic therapies targeting B cells in the treatment of relapsing multiple sclerosis (MS). More modest efficacy has been noted in the primary progressive subtype of MS. Clinical success has increased interest in the role of B cells in the patho...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2021-01-01
|
| Schriftenreihe: | Frontiers in Neurology |
| Schlagworte: | |
| Online-Zugang: | https://www.frontiersin.org/articles/10.3389/fneur.2020.595547/full |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|